Ratings by UBS (Lu Li)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/24/2026 | Myriad Genetics | MYGN | Maintain | Neutral (Neutral) |
|
Details | ||
| 2/12/2026 | Quidel Corp. | QDEL | Maintain | Neutral (Neutral) |
|
Details | ||
| 1/21/2026 | Quidel Corp. | QDEL | Maintain | Neutral (N/A) |
|
Details | ||
| 1/12/2026 | Veracyte, Inc | VCYT | Maintain | Buy (Buy) |
|
Details | ||
| 11/6/2025 | Quidel Corp. | QDEL | Maintain | Neutral (Neutral) |
|
Details | ||
| 11/4/2025 | Myriad Genetics | MYGN | Maintain | Neutral (Neutral) |
|
Details | ||
| 8/19/2025 | Myriad Genetics | MYGN | Maintain | Neutral (Neutral) |
|
Details | ||
| 8/7/2025 | Quidel Corp. | QDEL | Maintain | Neutral (Neutral) |
|
Details | ||
| 8/5/2025 | Fulgent Genetics | FLGT | Upgrade | Buy (Neutral) |
18.53 (14.63) |
-21.05% | Details | |
| 5/8/2025 | Quidel Corp. | QDEL | Maintain | Neutral (Neutral) |
|
Details | ||
| 5/7/2025 | Myriad Genetics | MYGN | Maintain | Neutral (Neutral) |
|
Details | ||
| 2/25/2025 | Myriad Genetics | MYGN | Maintain | Neutral (Neutral) |
|
Details | ||
| 2/13/2025 | Quidel Corp. | QDEL | Maintain | Neutral (Neutral) |
|
Details | ||
| 12/10/2024 | Myriad Genetics | MYGN | New Coverage | Neutral (N/A) |
15.13 (5.15) |
-65.96% | Details | |
| 11/8/2024 | Quidel Corp. | QDEL | Maintain | Neutral (N/A) |
|
Details | ||
| 9/19/2024 | Quidel Corp. | QDEL | New Coverage | Neutral (N/A) |
46.23 (20.83) |
-54.94% | Details |
